$11.98 WBA Walgreens Boots Alliance (NASDAQ) 08 Jan 2026: intraday $11.98, $10.50 PT
WBA stock is trading at $11.98 intraday on the NASDAQ in the United States, up $0.06 or 0.50% as volume spikes to 452081061.00 shares. The move follows heavy trading versus a 50-day average of 16940296.00 shares and keeps the share price between the 50-day average of $11.66 and the 200-day average of $10.81. Investors are watching analyst price targets and the company’s cash and debt metrics as Walgreens Boots Alliance, Inc. (WBA) navigates margin pressure and portfolio shifts.
WBA stock intraday action and volume
WBA stock is trading at $11.98 with a one-day change of $0.06 and intraday volume of 452081061.00, which is 26.69 times the average. The volume surge is the main driver of WBA being among the most active NASDAQ names today and suggests short-term traders are repositioning ahead of news flow.
Catalysts and recent WBA news
Market attention has concentrated on strategic developments and Wall Street coverage; MarketBeat reports recent news and an updated price-target consensus. See MarketBeat coverage of WBA news for details source. Analysts currently list a consensus target of $10.50, and MarketBeat’s forecast page gives context on latest estimates source.
WBA fundamentals and valuation
Walgreens Boots Alliance, Inc. shows a market capitalization of 10369421068.00 USD, trailing EPS of -7.29 and a negative PE of -1.64, reflecting recent net losses and non-cash items. Price-to-book sits at 1.44 and enterprise value to sales is 0.25, which signals low revenue valuation but elevated leverage with debt-to-equity of 4.04.
WBA stock technical snapshot
Technically the stock shows RSI at 100.00 and an ADX of 50.00, indicating a strong intraday trend and overbought short-term readings. Price is above the 50-day average ($11.66) and 200-day average ($10.81), but ATR is modest at 0.16, so intraday moves are rapid on heavy flow rather than broad volatility expansion.
Meyka AI grade and analyst consensus for WBA
Meyka AI rates WBA with a score out of 100: Meyka AI rates WBA with a score of 63.38 / 100, Grade B, Suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. External analyst consensus currently shows 0 Buys, 1 Hold and 2 Sell ratings, with a target consensus of $10.50, implying downside versus the current $11.98 market price.
Risk drivers and opportunities for WBA stock
Key risks include high leverage, negative EPS and thin liquidity metrics tied to balance-sheet restructuring; debt-to-equity at 4.04 amplifies these risks during sales slowdowns. Opportunities include retail health initiatives, pharmacy services growth and any successful cost restructuring that could expand margins and free cash flow relative to current pfcf ratio of 17.88.
Final Thoughts
Key takeaways for WBA stock: shares trade at $11.98 on the NASDAQ with outsized intraday volume of 452081061.00 shares, keeping the stock among the market’s most active names. Analyst price-target consensus is $10.50, implying -12.35% versus the current price. Meyka AI’s forecast model projects a one-year level of $8.36, implying a potential -30.16% downside from $11.98; forecasts are model-based projections and not guarantees. Operationally, weak EPS (-7.29) and a high debt-to-equity ratio (4.04) are material headwinds, while the retail pharmacy footprint and specialty services are the primary recovery levers. For intraday traders the setup is volume-driven and momentum-focused; for longer-term investors the valuation needs to be weighed against leverage and earnings recovery prospects. This analysis is informational; we are an AI-powered market analysis platform and not investment advisors.
FAQs
What is the current price of WBA stock?
WBA stock is trading at $11.98 intraday on the NASDAQ with a one-day change of $0.06 and volume of 452081061.00 shares at the time of this report.
What price targets do analysts have for WBA?
Analyst consensus target for WBA is $10.50, with a range from $9.00 to $12.00, implying about -12.35% from the current $11.98 price.
How does Meyka AI rate WBA stock?
Meyka AI rates WBA with a score of 63.38/100, Grade B, Suggestion HOLD; the grade factors in benchmark and sector comparisons, growth, metrics and analyst views.
What are the main risks for WBA investment?
Primary risks for a WBA investment are high leverage (debt-to-equity 4.04), negative EPS (-7.29), and execution risk on margin recovery amid retail pressure and industry changes.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
